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ABSTRACT
Purpose: To evaluate the feasibility and efficacy of deep regional hyperthermia with the use of mobile
insulator sheets in a capacitively coupled heating device.
Materials and methods: The heat was applied using an 8-MHz radiofrequency-capacitive device. The
insulator sheet was inserted between the regular bolus and cooled overlay bolus in each of upper and
lower side of the electrode. Several settings using the insulator sheets were investigated in an experi-
mental study using an agar phantom to evaluate the temperature distributions. The specific absorption
rate (SAR) distributions in several organs were also computed for the three-dimensional patient model.
In a clinical prospective study, a total of five heating sessions were scheduled for the pelvic tumours,
to assess the thermal parameters. The conventional setting was used during the first, third and fifth
treatment sessions, and insulator sheets were used during the second and fourth treatment sessions.
Results: In the phantom study, the higher heating area improved towards the centre when the mobile
insulator sheets were used. The subcutaneous fat/target ratios for the averaged SARs in the setting
with the mobile insulator (median, 2.5) were significantly improved compared with those in the con-
ventional setting (median, 3.4). In the clinical study, the thermal dose parameters of CEM43CT90 in
the sessions with the mobile insulator sheets (median, 1.9min) were significantly better than those in
the sessions using a conventional setting (median, 1.0min).
Conclusions: Our novel heating method using mobile insulator sheets was thus found to improve the
thermal dose parameters. Further investigations are expected.
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Introduction
Hyperthermia (HT) is usually defined as a temperature eleva-
tion in the range of 39–45 degrees, and temperatures
beyond this range are considered as thermal ablation [1]. HT
is known to have a directly cytotoxic effect on cancer cells,
while also acting as a radio-sensitiser and a chemo-sensitizer
[1]. The efficacy of radiotherapy (RT) plus HT in various can-
cers was demonstrated and confirmed by randomised phase-
III clinical trials [2–6]. In the experimental setting, substantial
radiosensitisation was observed at temperatures of >41 C,
and there was a clear thermal–dose effect relationship in sen-
sitisation [7–14]. Numerous reports on superficial and deep-
seated tumours treated with RT plus HT have indicated a
positive interrelationship between thermal parameters and
clinical outcomes [5,15–17]. However, in deep-seated
tumours, it can often be difficult to increase the temperature
to >41.0 C [18]. In Japan, an 8MHz radiofrequency HT
device using capacitively coupled heating method has been
widely used for deep regional HT [19,20]. In such a device,
the distribution of the electric field is adjusted by changing
the size of the paired electrodes; for deep regional heating,
the coupled electrodes must be >25 cm in diameter [21].
Thus, an extensive area including the tumour of human body
is heated needlessly. Because the application of heat over an
extensive area causes physical fatigue and the preferential
heating of the subcutaneous fat tissue, which is associated
with pain or thermal burn, a good temperature increase to
>41.0 C is not obtained in a number of patients who
undergo deep regional HT using capacitive devices.
A few reports published from the 1980 s to the 1990 s
have suggested the potential utility of insulators or low-SAR
materials inserted into the heating applicator associated with
a large electrode to change the temperature distribution of
the deep-heating target in regional HT using a capacitive
device [22,23]. However, to our knowledge, no further clinical
experience or development of methods using insulators or
low-SAR materials has been reported. We hypothesised that
the use of large electrodes with mobile insulator sheets
might be able to change the electric field distribution and be
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used to optimise the deep-heating area in order to achieve
an improved temperature increase at the heating target. The
purpose of this study was to evaluate the feasibility and effi-
cacy of deep regional HT using a capacitively coupled heat-
ing device with mobile insulator sheets in phantom,
numerical simulation and prospective clinical studies.
Materials and methods
The heating device
Heat was applied using an 8-MHz radiofrequency-capacitive
heating device (Thermotron RF-8, Yamamoto Vinita Co.,
Osaka, Japan). The physical features of the HT machine and
the thermal distribution have been previously reported in
phantoms and in the human body [21,24–26]. The patient is
placed between two electrodes connected to a high-power
RF generator. A pair of electrodes is connected to the pillars
of the gantry. The two electrodes can be independently
moved forward or backward by a hydraulic system. The sur-
face of the metal plate of the electrodes was covered with a
regular bolus composed of a sheet of flexible vinyl, and the
interior space between the vinyl sheet and the metal plate
was filled with 5% NaCl solution [27,28]. Overlay boluses
were applied in addition to regular boluses to broadly cool
the surface of the patient’s body, and to improve the cou-
pling of electrodes to the complex contours of the body. The
circulating liquid of the overlay bolus was saline water, 0.5%
NaCl; it was cooled by the circulatory system of the RF-8 dur-
ing heating. The rate of circulation and the temperature of
the overlay bolus were independently controlled. The tem-
perature of the overlay bolus was routinely kept at 5 C for
deep regional HT to reduce the preferential heating of the
superficial area.
The phantom and thermometry
The thermal profiles were investigated in a static phantom
during capacitive heating under various conditions based on
a previous phantom study of the 8-MHz radiofrequency-
capacitive device [21]. Rectangular phantoms (length: 29 cm,
width: 29 cm, height: 19 cm) were made of 4% agar gel con-
taining 0.2% NaCI, with 0.1% NaN3 used as a preservative
[29]. The phantom is usually applied to check the deep heat-
ing quality assurance for the 8-MHz radiofrequency-capacitive
heating device (Yamamoto Vinita Co., Osaka, Japan). Several
18-gauge catheter tubes were inserted into the phantoms
from the side and the thermocouples (Yamamoto Vinita,
LAS-4, Osaka, Japan) were placed in the tubes. The phantoms
were capacitively heated by concentrically coupling a pair of
electrodes with the upper and lower electrodes (both 30 cm
in diameter). The temperature distributions in the phantoms
were determined by moving the thermocouples through the
catheters before the start of the heating and immediately
after the completion of the heating. The time difference
between the first and last measurement point was about
15min. The measurements were made at a 2-cm interval.
Dwell time on one point was about 5 s.
The settings of conventional heating and heating with
silicone rubber sheets in the phantom study
Silicone rubber sheets were selected as insulator sheets.
The thickness of the silicone rubber was 0.5mm, 1.0mm or
1.5mm (Inoac Corporation, Nagoya, Japan; volume resistivity
value of 1015X  cm). Figure 1(a) shows the conventional set-
ting of the deep regional HT on the device; both the upper
and lower electrodes with a regular bolus of 30 cm in diam-
eter, overlay boluses cooled to 5 C by the circulatory system,
and an agar phantom. The centre of the agar phantom was
defined as zero point of the X, Y and Z coordinates. Heating
was performed under superficial cooling with overlay
Figure 1. (a) Pattern diagrams of the conventional setting in the phantom
study. (b) The distributions of the temperature increase in the phantom for the
conventional setting. The superficial area was cooled by the overlay bolus, while
the deep area was uniformly heated (with the exception of the external
border).
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boluses. The base line temperature of the phantom was 24
degrees. The starting time between the cooling the overlay
bolus and heating the phantom is simultaneous. The follow-
ing three settings were applied when using the silicone rub-
ber insulator sheet, in order to evaluate the temperature
increase with deep regional HT. (1) Insulator sheets with a
hole in the centre were inserted and attached to the front of
both regular boluses (Figure 2(a)); the thickness of the sili-
cone rubber was 0.5mm or 1.0mm. (2) Insulator sheets were
inserted in a circular sector shape at an angle of 270 with
an alternate arrangement and were attached to the front of
both regular boluses (Figure 3(a)); the thickness of the sili-
cone rubber was 1.5mm. (3) The insulator sheets were used
in the same manner as in setting number 2, with the excep-
tion that the regular boluses attached with the insulator
sheet were manually rotated in parallel at an angle of 90 at
5-min interval during heating (Figure 3(b)); this setting was
defined as the mobile insulator sheets setting. The required
time for the rotation was less than 5 s. Sono Jelly (Toshiba
Medical Supply Co., Ltd., Tokyo, Japan), which is generally
applied for ultrasound visualisation, was applied to a surface
of the overlay and regular boluses to avoid the air capsula-
tion and contact failure. Because the 8MHz capacitive heat-
ing device is open gantry system, the operator who took a
kneeling position could rotate easily the insulator sheets.
Patients did not need to get off the treatment table during
the rotation of the insulator sheets. Each heating session was
performed under a heating current at 7.5 A for 20min. The
output power and reflected power were adjusted as follows
to maintain the heating current at 7.5 A: 1350 W and 50 W
in the conventional setting, 1480W and 160W in setting
number 1 with 0.5-mm-thick insulator sheets, 1560W and
270W in setting number 1 with 1.0-mm-thick insulator
sheets, and 1610W and 330W in setting numbers 2 and 3.
3D simulations for specific absorption rate in
conventional heating and heating with silicone rubber
sheets
SAR distributions were computed using the low-frequency
(LF) solver of SIM4LIFE (version 3.2, ZMT, Zurich, Switzerland)
[30]. The LF-solver used a finite-element method (FEM). Each
simulation set-up for the agar phantom and 3D patient
model was based on the conventional setting, setting num-
ber 1 with 0.5-mm-thick insulator sheets, or setting number 3
at each position. The 3D patient model was reconstructed
with a computed tomography (CT) data set comprising 71 sli-
ces with a slice thickness of 5mm using the Medical Image
Segmentation Tool Set (iSEG, ZMT, Zurich, Switzerland).
Muscle, fat, bone and prostate were taken into account to
generate the 3D patient model. Furthermore, the subcutane-
ous fat (SF) was segmented and divided into eight parts by
ventrodorsal, left and right, and craniocaudal directions rela-
tive to a centre of the heating area. The frequency was
applied at 8MHz. Table 1 shows the electric conductivity
(S/m), relative permittivity and mass density (kg/m3) used for
Figure 2. (a) Pattern diagrams of the insulator sheet with a hole in the centre, defined as setting number 1. The insulator sheet was inserted between the regular
bolus and the cooled overlay bolus in both the upper and lower sides of the electrode. (b) The distribution of the temperature increase in the phantom with setting
number 1.
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the simulations. The values for the agar phantom were previ-
ously reported [29]. The size of each model in the simulation
was as follows: 23 megacells in the conventional setting
and setting number 3 with 1.5-mm-thick insulator sheets,
and 50 megacells in setting number 1 with 0.5-mm-thick
insulator sheets. The average SAR of the prostate (as a heat-
ing target) of all positions in setting number 3 using a con-
stant potential of 166.7 V was nearly equal to that of the
prostate in the conventional setting using 117 V. Therefore,
we decided to use these two constant potentials in order to
evaluate the difference in the SAR of the SF under the
equivalent SAR of the prostate among the different heating
methods. The Mann–Whitney U-test was used to evaluate
the differences in the SF/prostate ratio for averaged SARs
among the conventional setting, setting number 1 and set-
ting number 3.
Figure 3. (a) Pattern diagrams in the phantom for setting number 2. The insulator sheets were alternately arranged in a circular sector shape at an angle of 270
and were inserted between the regular bolus and cooled overlay bolus in both the upper and lower sides of the electrode. (b) Pattern diagrams of setting number
3 in which mobile insulator sheets were used. The insulator sheets, which were prepared in a circular sector shape, the same as in setting number 2, were manually
rotated in parallel at an angle of 90 at 5min intervals during heating. (c) The distribution of the temperature increase with setting number 2. (d) The distributions
of the temperature increase in setting number 3 in which mobile insulator sheets were used.
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The prospective clinical study
A prospective clinical study was planned based on setting
number 1 (using 0.5-mm silicone rubber sheets) and setting
number 3 of the phantom study. During definitive RT for
prostate cancer, five deep regional HT treatment sessions
were scheduled once weekly (one time/week). Conventional
heating was performed during the first, third and fifth treat-
ment sessions. Heating with the insulator sheets using set-
ting numbers 1 or 3 was performed during the second and
fourth treatment sessions. The eligibility criteria were as fol-
lows: an ECOG Performance Status of 0–1, normal liver and
renal functions, no pacemaker implantation, no haemato-
logical disorders, the presence of prostate carcinoma that
could be treated with definitive RT with deep regional HT
using an 8MHz radiofrequency capacitive heating device,
and cases in which the intra-rectal temperature could be
measured. These tumours were selected for the clinical pro-
spective trial for the following reasons: they were located in
the centre of the cross section of the pelvis, where it was
hypothesised that a favourable increase in temperature could
be achieved (based on the results of the phantom study);
and because the intra-rectal temperature was easily moni-
tored and was highly correlated with the tumour tempera-
ture [31,32]. The protocol of the clinical prospective study
was approved by the Institutional Review Board of our insti-
tution. Written informed consent for the clinical prospective
study was obtained from all of the patients.
Definitive RT was planned conventionally, with treatments
performed once daily five times/week using a 10-MV linear
accelerator. The centre of the heating area was fitted to the
cutaneous markings of the RT-isocentre, which was located
at the centre of the prostate. The treatment posture for all
cases was the prone position. The patients were carefully
instructed to alert the operator of any unpleasant sensations,
such as pain suggestive of a hot spot, respiratory problems
or palpitation. The RF-output was increased to the maximum
level tolerated by the patients, following the appropriate
adjustments of the treatment setting, and the patient's toler-
ance threshold was established based on their response. The
goal was to continue the treatment for 50min. In the ses-
sions in which setting number 3 (mobile insulator sheets)
was applied, regular boluses attached to the insulator sheet
were manually rotated in parallel at an angle of 90 at 5-min
interval; if subcutaneous pain near the non-insulated area
emerged, the regular boluses attached to the insulator sheet
could be rotated earlier.
The intra-rectal temperature was measured using a 4-point
micro-thermocouple sensor (Yamamoto Vinita, LAS-4, Osaka,
Japan) which was inserted into the rectum, at the level of
the prostate. The temperature was automatically recorded
each minute during HT. The Tx is an index temperature, indi-
cating when the temperature was reached or exceeded by
x% of the intra-rectal measurement points. The CEM43CT90
has been used extensively and successfully in clinical trials to
assess the efficacy of heating [14,33–36] and represents the
thermal isoeffect dose expressed in cumulative equivalent
minutes at a reference temperature of 43 C, based on the
low end of the temperature distribution (T90), and was calcu-
lated from the time-temperature data using the following
formula:
CEM43CT90 ¼
Xn
i¼ 0
tiR
ð43T90iÞ
When the temperature is higher than 43 C, R¼ 0.5. When
the temperature is lower than 43 C, R¼ 0.25. In this protocol,
ti was the time interval of the ith sample (ti¼ 1.0min). The
temperature exceeding the temperature at 90% of the intra-
rectal measurement points during the ith minute was desig-
nated as T90i. We then used the CEM43CT90 to convert
each T90i into an equivalent time at 43 C and then to calcu-
late the sum of these equivalent times over the entire treat-
ment duration of n minutes. The Mann–Whitney U-test was
used to evaluate differences in thermal parameters among
the sessions with the conventional setting, the setting
number 1 and the setting number 3.
The toxicity of therapy was evaluated according to the
Common Terminology Criteria for Adverse Events version 3.0.
The highest toxicity for each patient during and after RT with
HT was entered into the toxicity analysis. Toxicity was
defined as either acute (occurring during therapy or up to
3months after therapy) or late (occurring more than
3months after the completion of therapy).
Results
The distribution in the increase in temperature in the phan-
tom study after heating using the conventional setting is
shown in Figure 1(b). Most areas in the phantom were uni-
formly heated, with the exception of the superficial area
(Y 6 cm), which was cooled by the overlaying bolus, and
the outside edge (X 8 cm). Figure 2(b) shows the distribu-
tion of the temperature increases using setting number 1.
When 0.5-mm-thick insulator sheets were applied, the area in
which a greater temperature increase occurred narrowed
towards the centre of the X-axis. On the other hand, the area
with a greater temperature increase was broadened towards
the Y-axis until the superficial area, despite the superficial
area was under superficial cooling. When 1.0-mm-thick insu-
lator sheets were used, the temperature gradient was more
prominent than that observed with the 0.5-mm-thick insula-
tor sheets. Figure 3(c) shows the distribution of the tempera-
ture increases using setting number 2. The area with a
greater temperature increase was wider towards the non-
insulated area, which was not covered by the insulator sheet
Table 1. Dielectric and materials properties used for the simulations at 8MHz.
Materials
Electric
conductivity
(S/m)
Relative
permittivity
Mass
density
(kg/m3)
Regular boluses (5% NaCl at 10 C) 6.31 82 1000
Overlay boluses (0.5% NaCl at 5 C) 0.57 85 1000
Agar phantom 0.59 81 1020
Bone 0.04 43 1908
Muscle 0.61 203 1090
Prostate 0.67 305 1045
Fat 0.05 33 911
Silicon rubber 1.00E-14 3 1000
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on the electrode, while the lower heating area was wider
toward the insulated area on the electrode. Figure 3(d)
shows the distributions of the temperature increases using
setting number 3, in which mobile insulator sheets were
used. The greater heating area improved in a direction
towards the centre on the X-axis (6 cm), Y (4 cm) and the
Z-axis (4 cm). SAR distributions using the numerical 3 D sim-
ulations in the conventional setting, setting number 1 and
setting number 2 which is the same as setting number 3 at
each position are shown in Figure 4. The SAR distributions
for each setting in the agar phantom using the numerical 3 D
simulations were generally consistent with the temperature
distribution, except for the high-SAR regions in the superficial
areas, which were cooled by overlay boluses.
The SAR distributions using the 3D anatomical model in
the conventional setting and settings number 1 and 3 are
shown in Figure 5. In the conventional setting, the SF areas
where the overlay bolus made contact consistently showed a
high SAR (Figure 5(c,d)). In setting number 1, the SF areas in
which a greater SAR increase occurred showed modest
Figure 4. (a) Pattern diagrams for the 3 D SAR simulation using the agar phantom. (b) SAR distribution in the phantom for the conventional setting. (c) SAR distri-
bution in the setting number 1. (d) SAR distribution in the setting number 1 at an oblique angle. (e) SAR distribution in setting number 3 at position #1. (f) SAR dis-
tribution in setting number 3 at position #1 at an oblique angle.
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narrowing towards the centre of the electrode compared
with those in the conventional setting. However, most of the
SF area where the overlay bolus made contact still showed
high SAR (Figure 5(e,f)). In setting number 3, the SAR
increase was well suppressed in the area where covered by
the insulator sheets, while the areas with high SAR were
located in the SF areas not covered by the insulator sheets
(Figure 5g-5j).
Table 2 shows the results of the 3D SAR simulations using
the 3D patient model. In setting number 3, the average and
Figure 5. (a) Segmented CT slice of the caudal area showing the bone (blue), muscle (yellowish green), prostate (red) and subcutaneous fat (SF) of the right ven-
tral area (pink), left ventral area (white), right dorsal area (orange), left dorsal area (green) and other fat (yellow). (b) Colour scale bar of the SAR distribution.
(c) SAR distribution in the 3 D anatomical model for the conventional setting. Constant potential was set at 117 V. (d) Sagittal view of the SAR distribution in the
conventional setting. (e) SAR distribution in setting number 1. Constant potential was set at 166.7 V. (f) Sagittal view of the SAR distribution in setting number 1.
(g) SAR distribution in setting number 3 at position #1. Constant potential was set at 166.7 V for setting number 3. (h) Sagittal view of the SAR distribution in set-
ting number 3 at position #2. (i) SAR distribution in setting number 3 at position #3. (j) Sagittal view of the SAR distribution in setting number 3 at position #4.
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maximum local SAR of the insulated SF area was selectively
reduced in each position of the mobile insulator sheets,
while the average SARs of the prostate as the heating target
were maintained. The average SF/target ratios (median, 2.5;
range, 2.1–2.6.) among 4 positions for the average SAR in set-
ting number 3 were significantly lower than the SF/target
ratios (median, 3.4; range, 2.5–4.0) in the conventional setting
(p¼ .0063) (Table 2). The SF/target ratios (median, 2.9; range,
2.4–3.2) for the average SARs in setting number 1 tended to
be lower than those (median, 3.4; range, 2.5–4.0) in the con-
ventional setting (p¼ .066), albeit not to a significant degree
(Table 2).
In the clinical prospective study, which was performed at
our institution between June 2012 and October 2012, 10
patients (median age, 70 years; range, 61–78 years) with pros-
tate cancer were eligible for the setting number 1 (with the
0.5-mm-thick insulator sheets). Between December 2012 and
April 2013, nine patients (median age, 72 years; range,
62–77 years) with prostate cancer (n¼ 9) were eligible for the
setting number 3 (in which mobile insulator sheets were
used). For setting number 1, nine (90%) of the 10 patients
could complete the planned five HT sessions. The remaining
patient refused to undergo the fourth and fifth HT sessions.
All 10 patients could receive the planned definitive RT.
Table 3 shows the results of the thermal parameters in the
HT sessions with conventional settings and those with setting
number 1. There were no significant difference between the
conventional settings and setting number 1 with regard to
the heating duration and the thermal parameters; the ther-
mal dose of median CEM43CT90 in the conventional setting
and setting number 1 was 1.2min and 1.6min, respectively,
showing no significant difference. For setting number 3,
eight (89%) of the nine patients could complete the planned
five HT sessions. The remaining one patient refused to
receive the fourth and fifth HT sessions. All nine patients
could receive the planned definitive RT. Table 4 shows that
all of the thermal parameters in the sessions in which setting
number 3 was used were significantly better in comparison
to those in the sessions in which the conventional setting
was used; the thermal dose of median CEM43CT90 increased
from 1.0min to 1.9min. The averaged differences and com-
parison of the thermal parameters among order of the HT
sessions in setting number 3 are indicated in Table 5. There
was no significant difference in the duration of heating using
Table 2. Three-dimensional SAR simulations using the 3 D patient model.
Setting number 3
Conventional
setting
Conventional
setting
Setting
number 1 Position #1 Position #2 Position #3 Position #4 Average
Averaged SAR (W/kg)
Prostate 120.3 59.3 70.5 63.9 68.4 53.1 49.1 58.6
SF
Right cranial ventral 424.9 209.3 215.8 235.6 231.3 71.7 80.8 154.9
Left cranial ventral 419.2 206.5 207.6 69.6 220.2 234.5 79.1 150.9
Right cranial dorsal 481.7 237.3 225.1 82.6 82.8 214.2 197.0 144.1
Left cranial dorsal 462.1 227.6 218.4 208.4 78.5 81.6 195.5 141.0
Right caudal ventral 304.6 150.0 182.1 184.0 62.9 65.0 234.4 136.6
Left caudal ventral 295.2 145.4 171.5 59.8 60.8 183.5 219.8 131.0
Right caudal dorsal 403.4 198.7 199.6 68.7 201.8 208.5 62.5 135.4
Left caudal dorsal 382.3 188.3 192.4 201.8 197.4 67.7 59.2 131.5
Other fat 164.7 81.1 88.6 58.7 60.5 58.7 64.5 60.6
Bone 60.0 29.6 31.6 21.5 21.1 21.1 19.4 20.8
Muscle 209.6 103.2 105.1 76.6 89.2 77.1 69.3 78.0
SF/target ratio for averaged SARs
Right cranial ventral/Prostate 3.5 3.5 3.1 3.7 3.4 1.4 1.6 2.5
Left cranial ventral/Prostate 3.5 3.5 2.9 1.1 3.2 4.4 1.6 2.6
Right cranial dorsal/Prostate 4.0 4.0 3.2 1.3 1.2 4.0 4.0 2.6
Left cranial dorsal/Prostate 3.8 3.8 3.1 3.3 1.1 1.5 4.0 2.5
Right caudal ventral/Prostate 2.5 2.5 2.6 2.9 0.9 1.2 4.8 2.3
Left caudal ventral/Prostate 2.5 2.5 2.4 0.9 0.9 3.5 4.5 2.4
Right caudal dorsal/Prostate 3.4 3.4 2.8 1.1 3.0 3.9 1.3 2.3
Left caudal dorsal/Prostate 3.2 3.2 2.7 3.2 2.9 1.3 1.2 2.1
Maximum local SAR (W/kg)
Prostate 1393 686 1005 408 670 347 356 445
SF
Right cranial ventral 15310 7540 7169 7571 5046 2474 3038 4532
Left cranial ventral 24120 11880 10120 4019 5147 12380 4739 6571
Right cranial dorsal 13180 6490 7104 2383 3256 4688 7914 4560
Left cranial dorsal 12000 5913 7236 3987 2690 2098 9173 4487
Right caudal ventral 34700 17100 17180 16090 4266 5608 7356 8330
Left caudal ventral 34300 16900 16670 5662 4479 16480 7394 8504
Right caudal dorsal 21520 10600 9350 4222 6053 9166 5981 6356
Left caudal dorsal 17360 8551 8526 10200 6359 4410 6299 6817
Minimum local SAR (W/kg)
Prostate 14.3 7.1 10.3 15.5 13.8 12.1 11.6 13.3
3 D: three-dimensional; SAR: specific absorption rate; SF: subcutaneous fat.The constant potential was set at 117 V. For the others, constant potential was set at 166.7 V.The average of all positions in setting number 3.
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the conventional setting and that using setting number 3.
The acute toxicities that occurred in the whole study popula-
tion (n¼ 21) were as follows: Grade 3 leukopenia (n¼ 1),
Grade 3 anaemia (n¼ 1), Grade 2 genitourinary (GU)
toxicity (n¼ 6, 29%), Grade 1 GU (n¼ 4, 19%), Grade 1
gastrointestinal (n¼ 2, 1%). Skin burn presenting as subcuta-
neous induration was observed in five patients (23%), but
spontaneously resolved after the completion of regional HT.
No late toxicity Grade 2 was observed.
Discussion
This is the first report to show that mobile insulator sheets
have a potential to optimise the distribution of the deep
heating area and achieve a greater temperature increase at
the central heating target using an 8MHz radiofrequency
capacitive heating device. This method is feasible and prom-
ising because the insertion of the mobile insulator sheets in
the current device is a simple method that does not involve
the major reconstruction of the heating device. As men-
tioned in the introduction, a significant disadvantage of RF
capacitive devices is their preferential heating of the subcuta-
neous fat tissue [37,38]. Because the depth at which the
bolus can cool the subcutaneous fat tissue is limited, the
thinner subcutaneous fat is a significant predictor of the
achievement of a good temperature increase of deep-seated
tumours [39–42]. Several previous reports have investigated
methods of improving the efficacy of RF capacitive devices in
deep regional heating [21,38,40,43,44]. Thermoesthesia near
the electrode edge can be reduced using an overlay bolus,
which is applied (in addition to the regular bolus) to minim-
ise the contact between the electrode edge and the body
surface [45,46]. Strong superficial cooling using an overlay
bolus, where the liquid close to the freezing point of water is
circulated, can suppress the preferential heating of the sub-
cutaneous fat tissue [38,40]. Rhee et al. showed the useful-
ness of precooling the subcutaneous fat tissue in deep
regional HT using an RF capacitive device [47]. Tomimatsu
et al. demonstrated a refinement of the circulating liquid of
the overlay bolus, and a substantial temperature increase in
deep regions was possible when 0.5% NaCl was used as the
overlay bolus circulating liquid [44]. Imada et al. showed that
heating in a prone position allows for a higher RF output ele-
vation and diminishes the degree of thermoesthesia in deep
regional HT for deep-seated intrathoracic tumours in com-
parison to the supine position [43].
Recently, however, Yahara et al. reported the clinical
experience in prostate cancer patients treated with RT plus
deep regional HT using a capacitive device in which a lower
CEM43CT90 was observed in 35 (47%) of 75 patients, des-
pite heating being performed using strong superficial cool-
ing, an overlay bolus with the refinement of the circulating
liquid and the patient in the prone position [42]. In the cur-
rent study, we demonstrated that the novel method using
mobile insulator sheets achieved significant improvements in
the thermal parameters in comparison to the conventional
setting, which included strong superficial cooling, an overlay
bolus the refinement of the circulating liquid and the prone
position. Based on these results, we consider the present
method to be promising and suggest that it should be
selected preferentially for patients in whom higher thermal
parameters cannot be achieved using the conventional set-
ting. In the phantom study, the insulator sheets with a
Table 3. The thermal parameters in the HT sessions with the conventional set-
ting and with setting number 1 (insulator sheets with a hole in the centre).
Thermal parameters
HT sessions with the
conventional
setting (n¼ 29)
HT sessions with
setting number 1
(n¼ 19) p
Heating duration (min.) .098
Mean 49.1 47.9
Median 50.0 50.0
SD 2.8 3.8
Range 40.0–50.0 37.0–50.0
Median T90 (C) .800
Mean 40.1 40.2
Median 40.4 40.8
SD 1.0 1.1
Range 37.8–41.5 38.3–41.5
Median T50 (C) .301
Mean 40.5 40.9
Median 40.8 41.3
SD 1.0 1.2
Range 38.1-41.6 38.5-42.4
Median T25 (C) .109
Mean 41.0 41.3
Median 41.3 41.8
SD 1.0 1.2
Range 38.7–42.2 38.8–42.8
CEM43CT90 (min.) .941
Mean 1.6 1.7
Median 1.2 1.6
SD 1.3 1.6
Range 0.0–5.4 0.0–5.2
Mann–Whitney U test.
Table 4. the thermal parameters in HT sessions with the conventional setting
and with setting number 3 (using mobile insulator sheets).
Thermal parameters
HT sessions with the
conventional setting
(n¼ 32)
HT sessions with
setting number 3
(n¼ 21) p
Heating duration (min.) .59
Mean 49.6 49.1
Median 50.0 50.0
SD 1.4 2.1
Range 44.0–50.0 44.0–50.0
Median T90 (C) .032
Mean 40.4 40.8
Median 40.6 40.8
SD 0.6 0.6
Range 39.1-41.5 39.7-41.6
Median T50 (C) .011
Mean 40.9 41.4
Median 41 41.2
SD 0.6 0.6
Range 39.7–42.0 40.0–42.1
Median T25 (C) .0075
Mean 41.2 41.7
Median 41.1 42
SD 0.6 0.6
Range 40.3–42.4 40.5–42.7
CEM43CT90 (min.) .025
Mean 1.3 2.5
Median 1.0 1.9
SD 1.1 2.0
Range 0.1–3.8 0.3–7.1
Mann–Whitney U-test.
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off-centre round hole (the setting number 1) led to greater
temperature increases in superficial central area, which could
not be cooled by superficial cooling using overlay boluses in
the phantom study. When 1.0-mm-thick insulator sheets with
a off-centre round hole were used, the temperature gradient
was more prominent than that observed with the 0.5-mm-
thick insulator sheets with a off-centre round hole. Therefore,
we judged that more than 0.5-mm-thick insulator sheets with
off-centre round hole, which would lead to much greater
temperature increases in superficial central area, cannot clinic-
ally be used. The 1.5-mm-thick sheets in a circular sector
shape (the setting number 2) consequently led to greater
temperature increases in superficial un-insulated area, which
also could not be cooled by superficial cooling in the phan-
tom study. However, the steering sheet (the setting number
3) could temporally shift the area of greater temperature
increases in superficial area and could inhibit the temperature
increases in the superficial area. The simulation results using
the 3D patient model demonstrated that the SAR of the insu-
lated SF area was selectively reduced in each position of the
steering insulator sheets, while the SARs of the heating target
were maintained. The SF/target ratios for the average SARs in
the setting with the mobile insulator were significantly
improved compared with those in the conventional setting. In
the clinical prospective study, we confirmed that this method
of the steering sheet (the setting number 3) could achieve a
significant increase in the thermal parameters of patients with
prostate in comparison to conventional heating. We are of
the opinion that this is a promising strategy for optimising
the deep heating area in this device. On the other hand, the
use of static setting number 1 with the 0.5-mm-thick insulator
sheets with off-centre round hole did not result in a signifi-
cant increase in the patients’ thermal parameters in the clin-
ical prospective study. We hypothesise that the main reason
for the higher temperature increase in the superficial area,
which results in pain, was that it occurred easily, even under
superficial cooling in setting number 1.
HT treatment planning (HTP) has recently been investi-
gated, with the aim of simulating temperature patterns as
well as SAR distributions and helping the operators visualise
the effects of different steering strategies in modern locore-
gional radiofrequency HT treatments [48,49]. Further investi-
gations using modern electromagnetic and thermal
simulation techniques may be useful for optimising the tem-
perature distribution with a high degree of accuracy using
current heating methods with mobile insulator sheets.
Achieving sufficiently high tumour temperatures is very
important for ensuring a good clinical outcome. Meta-
analyses to investigate the thermal parameters among the
four Phase III clinical trials showed that RT plus superficial HT
using higher tumour temperatures had significantly better
local control rates; on the other hand, the local control rate
of RT plus superficial HT using lower tumour temperatures
was almost the same as that of RT alone [17]. Yahara et al.
also showed that the addition of HT with higher thermal
parameters to RT may improve biochemical disease-free sur-
vival in patients with high-risk prostate cancer. In contrast,
there was no difference in the biochemical disease-free sur-
vival of the patients with lower thermal parameters and
those who were treated with RT alone [42]. These clinical
data clearly demonstrated that a higher tumour temperature
is required to enhance the RT effect in accordance with the
results of in vitro/in vivo studies [5,12]. Thus, our current
methods using the mobile insulator sheets to achieve a
higher tumour temperature may be useful for improving the
treatment results of combination therapy with RT plus deep
regional HT.
In summary, this is the first study to assess the effects of
mobile insulator sheets in the optimisation of the deep heat-
ing area in regional HT using a capacitively coupled heating
method. In the phantom study, the novel deep heating
method could improve the temperature in the central target
area. The mobile insulator sheets were able to improve the
SF/target ratios for the average SAR in the numerical simula-
tion. In the prospective clinical study, the novel methods
using the mobile insulator sheets was feasible and allowed
deep regional HT to be performed with higher thermal
parameters in patients with prostate cancer. Our proposed
methods do not require complex technology, are low cost
and can be applied uniformly among institutions using the
8-MHz radiofrequency-capacitive device. Further investiga-
tions, including studies involving modern HTP are justified to
improve this heating method.
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